长链非编码RNA OTX2-AS1促进髓母细胞瘤肿瘤生长并预测BCL-2抑制反应
该研究通过DNA拷贝数、甲基化与表达数据刻画OTX2-AS1在髓母细胞瘤中的分子改变,并在体外细胞模型和D283原位小鼠异种移植模型中做功能验证。结果显示OTX2与OTX2-AS1在部分髓母细胞瘤中扩增并连续过表达,OTX2-AS1敲除降低细胞活力和迁移并延长小鼠生存;BCL-2药理抑制可抑制OTX2-AS1过表达细胞的体外生长。
要点
- 部分髓母细胞瘤存在OTX2与OTX2-AS1扩增及连续过表达。
- OTX2-AS1启动子甲基化与OTX2-AS1表达相关。
- OTX2-AS1敲除在体外降低细胞活力与迁移,并延长D283原位小鼠生存。
核心结论
- 研究揭示OTX2-AS1在髓母细胞瘤中具有促肿瘤作用。
- 作者将BCL-2抑制确定为靶向OTX2-AS1过表达髓母细胞瘤细胞的潜在治疗途径。
研究设计与样本
- 研究采用髓母细胞瘤组织样本的DNA拷贝数改变、甲基化谱与基因表达数据分析。
- 研究进行髓母细胞瘤细胞模型体外分析及原位体内实验。
- 研究采用高通量药物筛选识别药理抑制剂,并用蛋白质组学与代谢组学分析药物作用机制。
主要发现
- 在部分髓母细胞瘤中检测到OTX2与OTX2-AS1扩增及连续过表达。
- OTX2-AS1启动子甲基化与OTX2-AS1表达相关。
- OTX2-AS1敲除在体外降低髓母细胞瘤细胞活力与细胞迁移。
- OTX2-AS1敲除在D283原位髓母细胞瘤小鼠异种移植模型中延长生存。
- BCL-2药理抑制在体外抑制OTX2-AS1过表达髓母细胞瘤细胞的生长。
临床怎么用
- 原文结论将BCL-2抑制描述为靶向OTX2-AS1过表达髓母细胞瘤细胞的潜在治疗途径。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Primary brain tumors are a leading cause of cancer-related death in children, and medulloblastoma is the most common malignant pediatric brain tumor. The current molecular characterization of medulloblastoma is mainly based on protein-coding genes, while little is known about the involvement of long non-coding RNAs (lncRNAs). This study aimed to elucidate the role of the lncRNA OTX2-AS1 in medulloblastoma. METHODS: Analyses of DNA copy number alterations, methylation profiles, and gene expression data were used to characterize molecular alterations of OTX2-AS1 in medulloblastoma tissue samples. In vitro analyses of medulloblastoma cell models and orthotopic in vivo experiments were carried out for functional characterization of OTX2-AS1. High-throughput drug screening was employed to identify pharmacological inhibitors, while proteomics and metabolomics analyses were performed to address potential mechanisms of drug action. RESULTS: We detected amplification and consecutive overexpression of OTX2 and OTX2-AS1 in a subset of medulloblastomas. In addition, OTX2-AS1 promoter methylation was linked to OTX2-AS1 expression. OTX2-AS1 knockout reduced medulloblastoma cell viability and cell migration in vitro and prolonged survival in the D283 orthotopic medulloblastoma mouse xenograft model. Pharmacological inhibition of BCL-2 suppressed the growth of OTX2-AS1 overexpressing medulloblastoma cells in vitro. CONCLUSIONS: Our study revealed a pro-tumorigenic role of OTX2-AS1 in medulloblastoma and identified BCL-2 inhibition as a potential therapeutic approach to target OTX2-AS1 overexpressing medulloblastoma cells.
引用
- Qin N, Paisana E, Picard D, et al. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma. J Neurooncol. 2023. PMID: 37976029. doi:10.1007/s11060-023-04508-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。